Kiniksa Pharmaceuticals Class A stock price

키닉사 파머슈티컬스 인터내셔널NASDAQ:KNSA · Nasdaq · Healthcare · sector #14
$79.78+1.31%
2026-10-09 close
Loading chart…

Kiniksa Pharmaceuticals Class A's chart data is dated 2026-10-09. Recorded technical signals: Near 52-week high, MA aligned, VCP, Bollinger breakout, MACD bullish cross. There are 10 published signal records.

Kiniksa Pharmaceuticals Class A last closed at $79.78 (+1.31%) on 2026-10-09. Signals today: Near 52-week high, MA aligned, VCP, Bollinger breakout, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is 82.5×. Its overall grade ranks 76 of 736 stocks in Healthcare.

About this company

Kiniksa Pharmaceuticals Class A last closed at $79.78 (+1.31%) on 2026-10-09. Signals today: Near 52-week high, MA aligned, VCP, Bollinger breakout, MACD bullish cross. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall A · 76/736

Valuation grade F

Details →

Related stocks

Details →

ETFs holding this stock

Innovator IBD 50 ETF · abrdn Focused U.S. Small Cap Active ETF · Virtus LifeSci Biotech Products ETF

Details →
About Kiniksa Pharmaceuticals Class A
What technical signals does Kiniksa Pharmaceuticals Class A (KNSA) have?
Kiniksa Pharmaceuticals Class A current technical signals: MA alignment (score 0.71).
Is Kiniksa Pharmaceuticals Class A a cup-and-handle pattern?
No. Kiniksa Pharmaceuticals Class A has no valid Cup signal right now.
What published figures are available for Kiniksa Pharmaceuticals Class A?
Market cap: $6.05B. Trailing 12 months PER: 82.5×. Latest quarter PBR: 10.17×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-10 dataset

Turn what you saw on this name into a strategy

Ask Q about Kiniksa Pharmaceuticals Class A, or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Kiniksa Pharmaceuticals Class A notifications

Quantus Signal · live data · not investment advice · Privacy Policy